NEI Podcast
The Neuroscience Education Institute (NEI) is dedicated to improving mental health care through innovative medical education. Each podcast episode features key opinion leaders discussing current topics in psychiatry and psychopharmacology. The show is designed for anyone interested in neuropsychiatric diseases and the latest treatment approaches, offering valuable insights for clinicians and enthusiasts alike.
Episodes
E292 - Re-release: Wired for Creativity? The Bipolar-Genius Connection with Dr. Tiffany Greenwood
Originally released in 2022, this episode of The PsychopharmaStahlogy Show features Drs. Andrew Cutler and Stephen Stahl in conversation with Dr. Tiffany Greenwood on the genetic and trait-based links between bipolar disorder and creativity. They explore how temperament, personality, and cognitive style may occupy the space between madness and genius, the role of dopamine, evolutionary explanati
E291 - Re-release: Recognizing and Treating Anhedonia with Dr. Vladimir Maletic
Originally released in 2024, this episode features the late Dr. Vladimir Maletic in conversation with Drs. Andy Cutler and Stephen Stahl about the clinical significance and neurobiology of anhedonia. They discuss its different dimensions, how it differs from emotional blunting, its relationship to functioning and treatment response, and practical approaches to assessment and treatment. The episod
E290 - ADHD and Substance Use Disorders: Treatment Challenges with Dr. Timothy Wilens
In this episode, Dr. Andy Cutler speaks with Dr. Tim Wilens about the complex relationship between attention-deficit/hyperactivity disorder (ADHD) and substance use disorders. They discuss how to distinguish ADHD from substance-related cognitive symptoms, determine when co-occurring conditions should be treated concurrently, and select appropriate ADHD medications based on the substance involved.
E289 - Recognizing and Managing the Biggest Mistakes in Psychopharmacology with Dr. Thomas Schwartz
Originally released in 2021, this episode features Dr. Thomas Schwartz discussing common mistakes in psychopharmacology and how psychiatric clinicians can recognize and manage them. He explores diagnostic uncertainty, medication dosing, informed consent and monitoring, and rational versus irrational polypharmacy. He also considers how clinicians can reassess inherited diagnoses, learn from prescr
E288 - PsychopharmaPearls: Kratom—What Clinicians Need to Know with Dr. William Sauvé
In this episode of PsychopharmaPearls, Dr. Andy Cutler and Dr. Will Sauvé discuss what clinicians need to know about kratom. They review why patients use it, signs of misuse, dependence, or withdrawal, and key pharmacologic and safety concerns. The conversation also offers practical guidance for discussing kratom use and incorporating it into treatment planning. William Sauvé, MD, is a board-c
E287 - Deprescribing Practices in Psychiatry with Drs. Stephen Stahl and Jeffrey Strawn
In this episode, Dr. Andy Cutler is joined by Drs. Stephen Stahl and Jeffrey Strawn to discuss deprescribing practices in psychiatry. They explore why deprescribing is an essential clinical skill, how to determine whether a patient still needs a medication, dose, or combination, and how to approach tapering in a way that balances relapse prevention, withdrawal risk, and patient-centered care. The
E286 - GLP-1 Agonists in Psychiatry: Beyond Weight Loss with Dr. Roger McIntyre
In this episode, Dr. Andy Cutler is joined by Dr. Roger McIntyre to discuss GLP-1 receptor agonists in psychiatry and why these medications may be relevant beyond weight loss. They explore the emerging role of GLP-1s in metabolic psychiatry, including potential connections with mood disorders, cognition, reward pathways, cardiometabolic health, and psychiatric medication-associated weight gain. D
E285 - Re-release: Eating Disorders, Nutrition, and the Brain with Dr. Cynthia Bulik
Originally released in June 2023, this episode features Dr. Cynthia Bulik in a discussion of eating disorders, nutrition, and the brain. The conversation explores anorexia nervosa, bulimia nervosa, binge eating disorder, ARFID, common misconceptions about eating disorders, and the evolving understanding of how biology, genetics, and environment shape risk, diagnosis, and recovery. Cynthia Bu
E284 - Nutritional Interventions in Psychiatry: Hype vs. Evidence with Dr. Bhagwan Bahroo
In this episode, Dr. Andy Cutler talks with Dr. Bhagwan Bahroo about nutritional interventions in psychiatry, including diet, supplements, metabolic health, inflammation, and the gut-brain axis. They explore where the evidence is strongest, where hype outpaces the data, and how clinicians can discuss nutritional strategies as adjunctive tools without losing focus on core treatments. Bhagwan A.
E283 - PsychopharmaPearls: When Akathisia Looks Like Agitation with Dr. Leslie Citrome
In this episode of PsychopharmaPearls, Dr. Andy Cutler talks with Dr. Leslie Citrome about akathisia, a common but often misdiagnosed antipsychotic side effect that can look like agitation, anxiety, irritability, or worsening psychiatric symptoms. They discuss how to recognize akathisia in clinical practice, distinguish it from true agitation, identify key timing and symptom clues, and avoid comm
E282 - 2026 NEI Spring Congress Extended Q&A: Anxiety, Schizophrenia, and Postpartum Mood Disorders with Drs. Strawn, Correll, and Payne
This episode features extended Q&A sessions addressing unanswered audience questions from select presentations delivered at the 2026 NEI Spring Congress in Kissimmee, Florida: (00:53) From Avoidance to Action: Evidence-based Pathways to Recovery for Difficult-to-Treat Anxiety by Jeffrey R. Strawn, MD, FAACAP (15:21) Perhaps the Grass Is Greener: Why, When, and How to Switch or Combin
E281 - ADHD, Hormones, or Aging? Sorting Out Cognitive Complaints in Women with Dr. Neill Epperson
In this episode, Dr. Andy Cutler speaks with Dr. Neill Epperson about how to evaluate cognitive complaints in women. They discuss how to differentiate between ADHD, hormonal changes (such as perimenopause), mood and anxiety disorders, and age-related cognitive decline. The conversation highlights key clinical clues, including symptom timing and fluctuation, to improve diagnostic accuracy. Practic
E280 - PsychopharmaPearls: Managing Rebound Insomnia with Dr. Thomas Schwartz
In this episode, Dr. Andy Cutler speaks with Dr. Thomas Schwartz about insomnia related to antidepressant discontinuation, including how rebound and withdrawal symptoms can emerge when tapering or stopping treatment. They review the underlying mechanisms, clinical risk factors, and how to distinguish discontinuation-related insomnia from relapse of depression or primary sleep disorders. The discu
E279 - Sleep in Bipolar Disorder: Clinical Insights with Dr. Holly Swartz
In this episode, Dr. Andy Cutler speaks with Dr. Holly Swartz about the critical role of sleep and circadian rhythms in bipolar disorder, including how sleep disturbance can function as both a symptom and trigger of mood episodes. They discuss how clinicians can better assess sleep to identify early warning signs of relapse, along with practical strategies for intervention, including applying pri
E278 - Re-release: Autism Spectrum Disorder and Comorbidities with Dr. Robyn Thom
In this revisited episode, Dr. Robyn Thom discusses autism spectrum disorder (ASD) and the psychiatric comorbidities that frequently accompany it. She reviews how ASD is diagnosed, the core domains of social communication differences and restricted or repetitive behaviors, and why treatment often focuses on co-occurring conditions such as anxiety, ADHD, sleep disorders, and agitation. Dr. Thom al
E277 - Shaping Recovery: Early Psychosis Outcomes and Engagement with Dr. Robert Cotes
In this episode, Dr. Andy Cutler talks with Dr. Robert Cotes about optimizing outcomes in early psychosis and why the first episode is a critical window for intervention. They discuss the impact of duration of untreated psychosis, recovery trajectories after a first episode, and what to measure beyond symptom reduction—including functional outcomes, cognition, and relapse risk. The conversation a
E276 - PsychopharmaPearls: Choosing Ketamine Treatment with Dr. Lisa Harding
PsychopharmaPearls is NEI's focused podcast series highlighting the clinical insights that can sharpen your prescribing decisions. In this episode, Dr. Andy Cutler talks with Dr. Lisa Harding about how to choose between IV ketamine and intranasal esketamine for patients with difficult-to-treat depression. They unpack the differences that truly matter in practice—from patient selection and monitor
E275 - Busting Myths About ADHD Medications with Dr. Tim Wilens
In this episode, Dr. Andy Cutler talks with Dr. Tim Wilens about enduring myths surrounding ADHD diagnosis and treatment, beginning with why misconceptions about overdiagnosis and misuse continue to shape clinical hesitation. They explore common misunderstandings about ADHD medications—including stimulants versus non-stimulants, concerns about diversion, personality changes, and long-term safety—
E274 - Busting Myths About Antipsychotics with Dr. Jonathan Meyer
In this episode, Dr. Andy Cutler speaks with Dr. Jonathan Meyer to dispel common myths about antipsychotic treatment, from concerns about sedation, personality change, and brain effects to misunderstandings about safety, long-acting injectables, and clozapine. The discussion focuses on what the evidence actually shows about efficacy, risk, and recovery, and how clinicians can communicate more cle
E273 - Busting Myths About Antidepressants with Dr. Jeffrey Strawn
In this episode, Dr. Andy Cutler and Dr. Jeff Strawn unpack common misconceptions that complicate real-world use of antidepressants. They review evidence on efficacy, suicidality risk, mechanisms, and early side effects, and discuss how to navigate hesitancy and misinformation. The conversation also addresses when to start medication, how to balance caution with timely intervention in youth, and
E272 - Our Most Downloaded Episode of 2025: Borderline Personality Disorder with Dr. Carla Sharp
As 2025 comes to an end, we revisit our most downloaded episode of the year. Join Dr. Andy Cutler and Dr. Carla Sharp as they explore the current conceptualization of borderline personality disorder (BPD), including diagnostic challenges, evidence-based treatments, and strategies to reduce stigma by framing BPD as a treatable condition. The conversation also highlights recent updates to the APA's
E271 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre
Join Drs. Andy Cutler and Roger McIntyre as they discuss the most significant advancements in psychopharmacology over the past year. Their conversation highlights groundbreaking developments and innovations in the field of psychiatry. Roger McIntyre, MD, FRCPC, is a globally recognized psychiatrist and psychopharmacologist who holds pivotal roles in academia, research, and leadership. His res
E270 - (CME) Complex Depression: Treating Beyond the Standard Algorithm
In this CME episode, Dr. Andy Cutler talks with Drs. Stephen Stahl and Roger McIntyre about recognizing and managing complex depression, particularly major depressive episodes with mixed or anxious features. They discuss how these specifiers affect diagnosis, symptom severity, and treatment response, and explore evidence-based strategies for optimizing outcomes through individualized and adjunctiv
E269 - (CME) Navigating Complexity: Personalized Treatment Approaches Across the Stages of Bipolar I Disorder
In this CME episode, Dr. Andy Cutler and Dr. Christoph Correll discuss the complexities of managing bipolar disorder, with a focus on recognizing and treating mixed states. They address overlapping manic and depressive symptoms, comorbidities, and the importance of shared decision-making, family involvement, and patient education. The conversation also explores strategies to improve adherence, the
E268 - 2025 NEI Fall Congress Extended Q&A with Drs. Brittany Albright, Lori Davis, Leslie Citrome, and Jeffrey Strawn
This episode includes extended Q&A sessions that address your unanswered questions from the following presentations delivered at the 2025 Fall Congress in Colorado Springs, Colorado: (00:22) A Discussion of Substance: Supporting Meaningful Improvements in the Lives of Patients Struggling With Substance Use Disorders by Brittany Albright, MD, MPH and Hara Oyedeji, DNP, PMHNP-BC (Q&A with Dr.
E267 - Re-release: Diagnosis, Treatment, and Pathophysiology of Catatonia with Dr. Joan Striebel
In recognition of Stress Awareness Week, the NEI Podcast revisits a vital conversation with Dr. Joan Striebel about the syndrome of catatonia—a condition that can emerge from profound psychological or physiological stress. Dr. Andy Cutler and Dr. Striebel discuss its dynamic presentation, the importance of treating underlying causes, and why clinicians should maintain a high index of suspicion wh
E266 - ADHD Treatment in the Real World: Prescribing Trends and Patient Outcomes with Dr. Ryan Sultán
In this episode, Dr. Andy Cutler talks with Dr. Ryan Sultán about the evolving landscape of ADHD—why diagnoses and prescriptions have risen across age groups, what recent prescribing data reveal, and how these trends align with real-world clinical experience. They explore how ADHD medications affect not just symptoms but broader outcomes like school, work, and safety, while also addressing concer
E265 - Beyond Dopamine: Evolving Strategies for Antipsychotic Switching in Schizophrenia with Dr. Peter Weiden
In this episode, Dr. Andy Cutler interviews Dr. Peter Weiden about when and how to switch antipsychotics in schizophrenia, tackling both the pitfalls and opportunities clinicians face in practice. They also explore how xanomeline–trospium has opened the door to treatments beyond dopamine and what this shift means for the future of care. Peter J. Weiden, MD, is a psychiatrist and internationall
E264 - (CME) Pediatric Bipolar Disorder: Differentiation, Treatment, and Transitioning to Adult Care
In this CME episode, Dr. Andy Cutler speaks with Dr. Manpreet Singh, the Robert H. Putnam Endowed Chair in Bipolar Research and Treatment at UC Davis, about the challenges of diagnosing and treating pediatric bipolar disorder. Dr. Singh shares evidence-based strategies for treatment, management of bipolar depression and medication side effects, and best practices for long-term care and trans
E263 - Men's Mental Health and the Transition to Fatherhood with Dr. Dan Singley
In this episode, Dr. Andy Cutler interviews Dr. Dan Singley about the unique challenges men face in recognizing, expressing, and seeking care for their mental health. They explore how norms around masculinity influence help-seeking behavior and contribute to men's heightened risk of suicide. The conversation also highlights the underrecognized issue of paternal perinatal depression, its impact on
E262 - Psychiatric and Neurological Symptoms of Long COVID with Dr. Roger McIntyre
In this episode, Dr. Andy Cutler interviews Dr. Roger McIntyre about the growing recognition of Long COVID and its wide-ranging neuropsychiatric manifestations. They discuss the role of neuroinflammation in its pathophysiology, the impact of these symptoms on patients' daily functioning, and both current and emerging treatment approaches. Dr. Roger McIntyre is a globally recognized psychiatris
E261 - When Trauma Compounds: Clinical Strategies for PTSD and mTBI in Veterans with Dr. Pamela Wall
In this episode, Dr. Andy Cutler interviews Dr. Pamela Wall about the complex intersection of PTSD and mild traumatic brain injury (mTBI) in veterans. They explore how military culture influences the experience and treatment of trauma, the challenges of distinguishing overlapping symptoms, and evidence-based strategies for assessment and intervention. Tune in for practical insights, clinical pear
E260 - How AI and Chatbots Are Shaping Mental Health Care with Dr. Steven Chan
In this episode, Dr. Andy Cutler interviews Dr. Steven Chan about the evolving role of artificial intelligence (AI) in psychiatry. They explore practical, real-world applications of AI in clinical settings, highlighting both the benefits and limitations of current technologies. The conversation also looks ahead to the future of AI in mental health care as advancements continue to accelerate. S
E259 - Why Clinicians Keep Coming Back to NEI Congress: A Behind-the-Scenes Chat
In this episode, Dr. Andy Cutler sits down with Dr. Debbi Morrissette, Senior Director of Educational Development at NEI, to explore the magic behind NEI Congress. Tune in as they talk about the unique elements of NEI Congress that bring the visual language of psychopharmacology to life! Are you ready to step up your clinical game? Join us at the 2025 NEI Fall Congress, Nov. 6–9 in Colorado Sp
E258 - The OCD Puzzle: Diagnosis, Treatment, and Innovation in Practice with Dr. Jeffrey Strawn
In this episode, Dr. Andy Cutler and Dr. Jeffrey Strawn explore the complexities of obsessive-compulsive disorder (OCD). Join the conversation as they discuss how OCD presents across different patients, evidence-based treatment approaches, and the critical role clinicians play in helping individuals manage symptoms and work toward remission. Jeffrey R. Strawn, MD, FAACAP is a Professor of Psy
E257 - (CME) Stimulating Solutions: Advances in Treating Stimulant Use Disorders
In this CME podcast episode, Dr. Andrew Cutler interviews Dr. Phillip Coffin, Director of the Center on Substance Use and Health in San Francisco, CA, about the management of stimulant use disorders. They explore the challenges of treatment and highlight the importance of harm reduction strategies to enhance patients' quality of life. NEI Members can earn CME/CE by participating in this activ
E256 - Distorted Reflections: Identifying and Treating Body Dysmorphic Disorder with Dr. Katharine Phillips
Today, Dr. Andy Cutler interviews Dr. Katharine Phillips about identifying and treating body dysmorphic disorder (BDD). Join the discussion as they talk about how BDD presents, the treatments available for this debilitating disorder, and how clinicians can help their patients reach remission. Katharine Phillips, MD is a renowned psychiatrist and leading authority on body dysmorphic disorder (
E255 - 2025 NEI Spring Congress Extended Q&A with Dr. Andrew Cutler, Desiree Matthews, Dr. Raj Mago, and Hara Oyedeji
This episode includes extended Q&A sessions that address your unanswered questions from the following presentations delivered at the 2025 Spring Congress in Philadelphia, Pennsylvania: (00:20) All the Tea on ADHD: Guidance for Developing Effective Treatment Strategies for Patients With ADHD by Andrew Cutler, MD (20:20) You and I and an LAI: Benefits, Early Adoption, and Options for
E254 - Breaking the Cycle: Medication Approaches to Hormonal Mood Disorders Across the Lifespan with Dr. Jennifer Payne
In this episode, Dr. Andy Cutler is joined by Dr. Jennifer Payne to discuss management of mood disorders influenced by fluctuations in reproductive hormones, particularly in women. They explore medication management during the perinatal period, emphasizing the risks associated with inadequately treated mood disorders. The conversation also addresses strategies for managing hormone-related mood di
E253 - Strategies to Identify and Treat Binge Eating Disorder with Dr. Cynthia Bulik
Join Dr. Andy Cutler and Dr. Cynthia Bulik as they discuss the challenges of diagnosing and treating binge eating disorder (BED). They explore the genetics, neurobiology, and clinical course of BED that inform treatment decisions, and examine how advances in genetic research and emerging pharmacological options may improve outcomes for individuals with BED. Cynthia Bulik, PhD, FAED is a Disti
E252 - The Latest in Diagnosing and Treating Borderline Personality Disorder with Dr. Carla Sharp
Join Dr. Andy Cutler and Dr. Carla Sharp as they discuss the current conceptualization of borderline personality disorder (BPD), including diagnostic challenges, evidence-based treatments, and strategies to reduce stigma by framing BPD as a treatable condition. The conversation also covers recent updates to the APA's BPD guidelines. Carla Sharp, PhD is a distinguished clinical psychologist spe
E251 - (CME) Prescribing Potentially Unsafe Drug Combinations in Treatment-Resistant Cases
In this CME podcast, Dr. Andrew Cutler and Dr. Roger McIntyre discuss the use of potentially unsafe drug combinations in patients with treatment-resistant psychiatric conditions. They review situations where complex medication regimens may be necessary and how clinicians may proceed in these instances. By addressing these topics, the podcast offers guidance on balancing the potential benefits of
E250 - Sexual Dysfunction: The Least Talked about Side Effect with Anita Clayton, MD
Join Dr. Andy Cutler as he speaks with Dr. Anita Clayton about one of the most common yet least discussed side effects of psychotropic medications—sexual dysfunction. They explore the different aspects of sexual dysfunction that may arise as a side effect, how to distinguish these from symptoms of psychiatric or medical disorders, and how to collaborate with patients to effectively address this c
E249 - Unintended Effects of FDA Pediatric Antidepressant Boxed Warnings with Christine Moutier, MD
Join Dr. Andy Cutler as he speaks with Dr. Christine Moutier about the unintended effects of the FDA boxed warnings on antidepressant use in pediatric patients—specifically, the underdiagnosis and undertreatment of depression. Their conversation highlights the importance of effectively treating depression to reduce suicide across the lifespan. Christine Yu Moutier, MD is a leading psychiatrist
E248 - Benzodiazepine Tapering and Deprescribing with Dr. Jeffrey Strawn
Join Dr. Andy Cutler as he talks with Dr. Jeffrey Strawn about how clinicians can determine the appropriate scenarios for benzodiazepine deprescribing, best practices for benzodiazepine tapering, and how to balance patient preferences to ensure best outcomes. Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at
E247 - Pediatric Psychopharmacology Series: Incorporating CBT in the Med Check with Dr. Katherine Dahlsgaard
In this episode of our special pediatric psychopharmacology series, Dr. Jeffrey Strawn and Dr. Katherine Dahlsgaard review how psychiatric prescribers can incorporate cognitive behavioral therapy (CBT) practices into medication checks with pediatric patients who have anxiety disorders. Specifically, they discuss the importance of using exposures to reduce avoidance behaviors that are characteristi
E246 - ECT Unveiled: Modern Perspectives in Psychiatric Treatment with Dr. Descartes Li
Join Dr. Andy Cutler as he talks with Dr. Descartes Li about the facts and fiction of electroconvulsive therapy (ECT). They discuss the efficacy and potential side effects of ECT, as well as the importance of educating patients and clinicians on ECT in order to overcome stigma associated with this life-saving treatment. Descartes Li, MD is a psychiatrist who specializes in caring for patients
E245 - The Best of the PsychopharmaStahlogy Show
In this special episode, we present highlights from the PsychopharmaStahlogy Show, hosted by Dr. Andy Cutler and featuring Dr. Stephen Stahl. Join us as we share clips from the most popular episodes of the series, showcasing some of the most though-provoking moments. (01:13) Clip from Treating ADHD Across the Lifespan with Dr. David Goodman (16:16) Clip from Management of Complex Treatment-Re
E244 - Pediatric Psychopharmacology Series: Pharmacological Management Strategies in Autism with Dr. Robyn Thom
In this episode of our special pediatric psychopharmacology series, Dr. Jeffrey Strawn and Dr. Robyn Thom discuss the situations in which psychotropic medications are appropriate for children with autism spectrum disorder. They also explore strategies for managing side effects of these medications, including cases involving polypharmacy in this population. Jeffrey R. Strawn, MD is a Professor
E243 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre
Join Drs. Andy Cutler and Roger McIntyre as they discuss the most significant advancements in psychopharmacology over the past year. Their conversation highlights groundbreaking developments and innovations in the field of psychiatry. Resources This Month in Psychopharmacology Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: https://nei.glob
E242- (CME) Past, Present, and Future: Muscarinic-Targeting Treatments for Schizophrenia
In this CME podcast, Dr. Andrew Cutler interviews Dr. Jonathan Meyer about the history of muscarinic receptor science in schizophrenia and how that informs the mechanisms of action of novel muscarinic-targeting drugs for this disorder. They also discuss the efficacy and safety of these drugs and provide practical strategies for prescribing xanomeline-trospium. Create a free NEI guest account
E241 - Pediatric Psychopharmacology Series: Using Lithium in Child and Adolescent Psychiatry with Dr. Adelaide Robb
In this episode of our special pediatric psychopharmacology series, Dr. Jeffrey Strawn and Dr. Adelaide Robb explore the nuanced use of lithium in treating bipolar disorder among children and adolescents. Their discussion delves into critical aspects of lithium treatment, including carefully calibrated dosing regimens, comprehensive side effect management, and the essential role of parental invol
E240 - 2024 NEI Congress Extended Q&A with Dr. Katherine Dahlsgaard, Dr. Roger McIntyre, Dr. Thomas Schwartz, and Lisa Tremayne
This episode includes extended Q&A sessions that address your unanswered questions from the following presentations delivered at the 2024 Congress in Colorado Springs, Colorado: (00:23) Panic On the Playground! Managing Social Anxiety in Pediatric Patients by Katherine Dahlsgaard, PhD, ABPP and Jeffrey Strawn, MD (Q&A with Dr. Dahlsgaard) (15:12) Inflammatory Remarks: Our Evolving Un
E239 - NEI Congress 20th Anniversary: Ask Me Anything with Dr. Stephen Stahl
In this special episode of the NEI Podcast, Dr. Andy Cutler interviews the founder of NEI, Dr. Stephen Stahl about the origins of NEI and the NEI Congress. They also field personal and clinical questions submitted my podcast listeners and NEI members across social media! Tune in for an insightful and fun conversation celebrating 20 years of NEI Congress! Never miss an episode!🎙SUBSCRIBE to the
E238 - (CME) From Treatment Plans to Patient Plans: Patients as Partners in Bipolar Disorder Treatment
In this CME episode, Drs. Andrew Cutler and Roger McIntyre discuss the challenges and importance of diagnosing bipolar disorder as early as possible in the course of the illness. They also review strategies to achieve a correct diagnosis to provide the most efficacious and tolerable treatments available for bipolar disorder. Create a free NEI guest account and obtain CME/CE by participating in
E237 - (CME) TD Realities: Patient Quality of Life with Tardive Dyskinesia
In this CME episode, Dr. Andy Cutler interviews Dr. Leslie Citrome about the impact of tardive dyskinesia on patient-reported outcomes and quality of life. They discuss how to correctly assess and diagnose tardive dyskinesia, as well as effective management strategies that incorporate the individual needs of patients. Create a free NEI guest account and obtain CME/CE by participating in this
E236 - Pediatric Psychopharmacology Series: Deprescribing in Child and Adolescent Psychiatry with Dr. John Walkup
In the first episode of a special pediatric psychopharmacology series hosted by Dr. Jeffrey Strawn, Dr. John Walkup joins the podcast to discuss deprescribing in pediatric patients. The conversation delves into the situations that warrant deprescribing from antidepressants, selecting the right time to do so, and dealing with relapse, as well as much more! Jeffrey R. Strawn, MD is a Professor a
E235 - Re-release: Traumatic Brain Injury in Victims of Intimate Partner Violence
This Domestic Violence Awareness Month, we're revisiting an important topic: the often overlooked risk of traumatic brain injury (TBI) among victims of intimate partner violence. Our goal is to shed light on this highly vulnerable group that frequently goes unnoticed in discussions about TBI. By reexamining a previous episode released in March 2020, we aim to raise awareness about the significant
E234 - Diagnosis, Treatment, and Pathophysiology of Catatonia with Dr. Joan Striebel
Join Dr. Andy Cutler as he talks with Dr. Joan Striebel about the syndrome of catatonia, including its dynamic presentation, treating the underlying disorder, and why clinicians must raise their index of suspicion when evaluating symptoms that could indicate catatonia is present. Dr. Joan Striebel is a psychiatrist at the California Department of State Hospitals, which is the largest forensic
E233 - (CME) Detecting and Treating Bipolar Disorder in Primary Care
In this CME episode, Dr. Andrew Cutler interviews Dr. Charles Vega about the challenges of identifying bipolar disorder in primary care and how to overcome them. They also discuss strategies for initiating and managing pharmacological treatment long term in collaboration with patients and psychiatric specialists. Create a free NEI guest account and obtain CME/CE by participating in this activi
E232 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Clozapine with Dr. Jonathan Meyer
What are the primary barriers to clozapine utilization in the United States, and how do these barriers impact patient care? What are some common misconceptions or negative attitudes among prescribers regarding clozapine, and how can these be addressed? What are some effective strategies for improving the management of clozapine's side effects to encourage its use? What strategies can be implement
E231 - The 2023 NEI Congress Young Investigator Poster Competition #1 Poster with Dr. Richard Price
Join Dr. Andy Cutler as he talks with the co-author of the winning poster from the 2023 NEI Congress Young Investigator Poster Competition, Dr. Richard Price. They discuss the objectives, design, and key findings of the poster titled, "Improved Mood and Weight Gain Mitigation Following Switch from Aripiprazole to Cariprazine." They also discuss the potential implications of these findings and app
E230 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: MAOIs with Dr. Thomas Schwartz
What are the main reasons MAOIs are underutilized in psychiatric practice despite their proven efficacy for certain conditions? What are the key dietary restrictions patients must follow when taking MAOIs? What are the critical drug-drug interactions clinicians must be aware of when prescribing MAOIs? What clinical pearls or tips would you give to clinicians looking to become more comfortable usi
E229 - Treatment Approaches for Smoking Cessation in the LGBTQIA+ Community with Dr. Rhonda Schwindt
What are the current smoking rates among LGBTQIA+ individuals compared to the general population? What unique barriers do LGBTQIA+ individuals face when trying to quit smoking? What are the recommended pharmacotherapies and behavioral interventions for smoking cessation? What training is needed for providers to deliver culturally affirmative smoking cessation treatment for LGBTQIA+ patients? D
E228 - (CME) Tardive Dyskinesia Today: Updates in the Current Landscape of Tardive Dyskinesia
In this CME episode, Dr. Andrew Cutler interviews Dr. Laxman Bahroo about the current landscape of tardive dyskinesia, including screening, diagnosis, and treatment. Practical strategies based on the latest data are reviewed at length, particularly for long-term management of tardive dyskinesia. Create a free NEI guest account and obtain CME/CE by participating in this activity here: https://
E227 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Lithium with Dr. Jonathan Meyer
What are the properties of lithium that make it a unique treatment option? What are the main reasons why lithium is underutilized in clinical practice, and what are the consequences of underutilization? What are the common myths or misconceptions about lithium's safety and tolerability? How can we better educate patients about the benefits of lithium and address concerns about side effects or mon
E226 - (CME) Symptoms Speak: Engaging Patients in the Tardive Dyskinesia Conversation
In this CME episode, Dr. Andrew Cutler interviews Desiree Matthews, PMHNP-BC on the importance of engaging patients across all facets of tardive dyskinesia management beginning with screening to symptoms monitoring to treatment. The role of patient experience and preferences in shared decision-making regarding treatment for tardive dyskinesia is discussed at length. Create a free NEI guest ac
E225 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Agitation with Dr. Leslie Citrome
How do symptoms of agitation manifest differently in disorders such as bipolar disorder, schizophrenia, and dementia, and what challenges does this pose for assessment? What are the most effective pharmacological treatments for acute agitation in psychiatric patients, and how do you determine the best course of action? How do cultural factors influence the approach to managing agitation in various
E224 - Is Cannabidiol Useful for the Treatment of Opioid Use Disorder? with Dr. Joji Suzuki
What are the hypothesized neurobiological mechanisms that support the use of cannabidiol (CBD) as a treatment for opioid use disorder (OUD)? How does CBD influence cue-induced craving in OUD? What are the challenges and opportunities in further exploring the use of CBD as a potential treatment for OUD? Dr. Joji Suzuki is the Director of the Division of Addiction Psychiatry and Director of Addict
E223 - 2024 NEI Synapse Extended Q&A: Diagnosing and Treating Comorbid ADHD and Bipolar Disorder with Dr. David Goodman
In this episode, Dr. David Goodman addresses your unanswered questions from his presentation, Setting the Mood: Strategies for Diagnosing and Treating ADHD in the Context of Bipolar Disorder, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
E222 - 2024 NEI Synapse Extended Q&A: Recognizing and Treating Mixed Features Across the Lifespan with Dr. Manpreet Singh
In this episode, Dr. Manpreet Singh addresses your unanswered questions from her joint presentation, Don't Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
E221 - 2024 NEI Synapse Extended Q&A: Diagnosis and Treatment of Alzheimer's Disease with Dr. Dani Cabral
In this episode, Dr. Dani Cabral addresses your unanswered questions from her presentation, Memories in the Future: An Update on the Diagnosis and Treatment of Alzheimer's Disease, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
E220 - 2024 NEI Synapse Extended Q&A: A Collaborative Approach to SMI Treatment with Dr. Sarah Vinson
In this episode, Dr. Sarah Vinson addresses your unanswered questions from her panel presentation, Serious Mental Illness: A Collaborative Approach, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
E219 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Cognitive Dysfunction with Dr. Richard Keefe
How does dysfunction in cognition affect overall treatment outcomes for psychiatric disorders? What are the challenges in treating cognitive deficits in psychiatric conditions? What treatments are in development for cognitive dysfunction? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of
E218 - Dementia Caregiving and the New GUIDE Model with Dr. Carolyn Clevenger
What are some common challenges faced by caregivers of individuals with dementia? What is comprehensive dementia care and how does it improve quality of life of individuals with dementia and their caregivers? What is the GUIDE Model and why is it needed? Carolyn Clevenger, DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA is a Professor at the Nell Hodgson Woodruff School of Nursing at Emory University.
E217 - Mindfulness-Based Stress Reduction for Anxiety Disorders with Dr. Elizabeth Hoge
What is the role of mindfulness techniques in the treatment of anxiety disorders and how is it evolving? How does mindfulness-based stress reduction compare to pharmacological treatment for anxiety disorders? What are the hypotheses that have been made about why mindfulness-based treatments work for anxiety? Elizabeth Hoge, MD is a Professor and Director of the Anxiety Disorders Research Program
E216 - Migrant and Refugee Mental Health with Dr. Lisa Fortuna
What are the cultural factors that should be considered when providing mental health care to migrant and refugee populations? What challenges and opportunities exist in providing mental health care to these communities? How can mental health professionals collaborate with other disciplines to create a holistic approach to address the mental health needs of migrant and refugee populations? Lisa
E215 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Anhedonia with Dr. Vladimir Maletic
How does anhedonia impact the overall treatment plan for patients with major depressive disorder and other psychiatric conditions? What are some of the most challenging aspects of treating anhedonia in patients? Are there any new treatments in development that may be helpful for treating anhedonia? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting,
E214 - Re-Release: Blazing Trails to Break Down Structural Racism and Improve Black Mental Health with Dr. Sarah Vinson
During Black History Month, we revisit an enlightening conversation with Dr. Sarah Vinson about the impact of structural racism on Black mental health and how mental healthcare providers can make a difference in the lives of patients by leveraging their privilege and skillsets. Dr. Sarah Y. Vinson is a physician who is triple-board certified in adult, child & adolescent, and forensic psychiat
E213 - The PsychopharmaStahlogy Show: Is The Trip Necessary? with Dr. Charles Raison
Can the therapeutic benefits of psilocybin be achieved without a psychedelic trip? What is the role of psychological support in the therapeutic effect of psilocybin? What is microdosing and what are its potential benefits and risks? What is the path to FDA approval and commercialization of psilocybin and other psychedelics? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackl
Recommended
Hard Knocks Podcast
Effective Weight Loss for Moms | High protein, Strength Training, Lose Weight, Meal Planning, Fat Loss, Healthy Habits
The Human-Animal Connection - Pet Life Radio Original
Infinite Health with Dr. Arasi Maran
The Daily
World News Tonight with David Muir
English Vocabulary Help
The Joe Rogan Experience
TED Talks Daily
Learn English B1 with Daily News | English Listening Practice
Talk About Talk - Executive & Leadership Communication Skills
English with Olivia | Slow Conversations & Vocabulary
